XENT News and Press, Intersect ENT Inc. From 02/24/20

Intersect ENT (NASDAQ: XENT ): Q4 GAAP EPS of -$0.25 beats by $0.10 . More news on: Intersect ENT, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Intersect ENT, Inc. (NASDAQ:XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today reported financial results for the fourth quarter and full year ended December 31, 2019. 2019 was a year of change for Intersect ENT. New company l...

Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will release fourth quarter and year 2019 financial results on February 24, 2020. The company expects to issue the release at approximately 7...

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 at the Lotte New York Palace in New York City, and will present in a session at 2:30 p.m. ET. A replay of the ses...

Intersect ENT, Inc. (NASDAQ: XENT), a company transforming care for patients with ear, nose and throat conditions, today reported preliminary unaudited revenue for the full year ended December 31, 2019. Full Year 2019 Preliminary Revenue Preliminary unaudited revenue for the full ye...

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 38 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at the Westin St. Francis Hotel in San Francisco, and will present at 1:30 p.m. PT. A replay of the session will be av...

SANTA CLARA, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that Jeri Hilleman has joined its Board of Directors, effective imme...

Intersect ENT ( XENT ) appoints Richard A. (Randy) Meier as EVP & CFO of the company, effective immediately. More news on: Intersect ENT, Inc., Healthcare stocks news, Read more ...

Richard A. Meier to serve as Executive Vice President and Chief Financial Officer Intersect ENT ® , Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the appointment of Richard A. (Randy) Meier as Execu...

Intersect ENT, Inc. (NASDAQ: XENT ) today announced that management will participate in the 31 st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City, and will present in a session at 4:30 pm ET. A replay of the session will be av...